No Data
Qingdao Vland Biotech INC. (603739.SH): plans to reduce the capital of its subsidiary Vland Pet by 60 million yuan.
On December 27, GELONGHUI reported that Qingdao Vland Biotech INC. (603739.SH) announced plans to reduce the capital of its wholly-owned subsidiary Vland Pet to 60 million yuan. After the completion of this capital reduction, Vland Pet's registered capital will decrease from 70 million yuan to 10 million yuan.
Qingdao Vland Biotech Gets China Nod for Bird Flu Vaccine, Treatment
Qingdao Vland Biotech INC. (603739.SH): Obtained a new veterinary drug registration certificate.
On December 23, Gelonghui reported that Qingdao Vland Biotech INC. (603739.SH) announced that, according to relevant regulations such as the "Veterinary Drug Management Regulations" and the "Veterinary Drug Registration Measures," the Ministry of Agriculture and Rural Affairs approved the joint application by Qingdao Vland Biotech INC. (hereinafter referred to as the "company") and its wholly-owned subsidiary, Qingdao Vland Animal Health Group Co., Ltd., along with Other units, to issue "Inactivated Vaccine for Newcastle Disease and Bird Flu (H9 Subtype) (LaSota Strain + WL-s Strain, Suspension Culture)" as a Class III new veterinary drug, and recently issued the "New Veterinary Drug Registration Certificate" (Announcement No. 860 by the Ministry of Agriculture and Rural Affairs). According to the "
Qingdao Vland Biotech INC. (603739.SH): Shareholders and directors, supervisors, and senior executives plan to collectively reduce their shareholding by no more than 0.9911%.
On December 17, Gelonghui announced that Qingdao Vland Biotech INC. (603739.SH) has disclosed that due to personal financial needs, Director Mr. Jia Deqiang and Director and CFO Mr. Qiao Piyuan plan to reduce their shareholding through centralized bidding within three months starting from 15 trading days after the announcement. The total number of shares to be reduced is not more than 2,507,800 shares, which accounts for no more than 0.9911% of the company's total share capital.
Qingdao Vland Biotech INC. (SHSE:603739) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Qingdao Vland Biotech's (SHSE:603739) Anemic Earnings Might Be Worse Than You Think